keyboard_arrow_up

Schistosomiasis Therapeutic Pipeline H1 2015 Review Research Report

RnRMarketResearch.com adds “Schistosomiasis – Pipeline Review, H1 2015“ report to its research database.

The report “Schistosomiasis – Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Schistosomiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Schistosomiasis and special features on late-stage and discontinued projects.

Complete Report Details @ http://www.rnrmarketresearch.com/schistosomiasis-pipeline-review-h1-2015-market-report.html .

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=382514 . (This is a premium report priced at US$2000 for a single user License)

Companies discussed in this report includes: BioDiem Ltd, Concert Pharmaceuticals, Inc., Kancera AB, LondonPharma Ltd.

Drugs profiles discussed in this report includes BDM-I,  D-Praziquantel,  intestinal schistosomiasis vaccine,  Small Molecule for Schistosomiasis,  Small Molecule for Schistosomiasis,

Featured News & Press Releases:

·         Aug 23, 2013: BioDiem US patent for skin and wound infections

·         Feb 08, 2013: BioDiem Progresses To Proof-Of-Concept Testing Of BDM-I Antimicrobial Effect Against Parasites

·         Nov 08, 2012: BioDiem Partners With Griffith University To Enhance Antimicrobial Drug BDM-I

·         Oct 18, 2012: BioDiem Reports Continued Progress In Development Of Antimicrobial BDM-I

·         Aug 08, 2012: BioDiem Receives European Patent For Antimicrobial Compound BDM-I

Table of Contents

List of Tables
Number of Products under Development for Schistosomiasis, H1 2015 7
Number of Products under Development for Schistosomiasis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Early Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Products under Investigation by Universities/Institutes, H1 2015 13
Schistosomiasis - Pipeline by BioDiem Ltd, H1 2015 14
Schistosomiasis - Pipeline by Concert Pharmaceuticals, Inc., H1 2015 15
Schistosomiasis - Pipeline by Kancera AB, H1 2015 16
Schistosomiasis - Pipeline by LondonPharma Ltd, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 19
Number of Products by Stage and Mechanism of Action, H1 2015 20
umber of Products by Stage and Route of Administration, H1 2015 21
Number of Products by Stage and Molecule Type, H1 2015 23
Schistosomiasis Therapeutics - Recent Pipeline Updates, H1 2015 29
Schistosomiasis - Dormant Projects, H1 2015 31

List of Figures
Number of Products under Development for Schistosomiasis, H1 2015 7
Number of Products under Development for Schistosomiasis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 11
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Molecule Types, H1 2015 22
Number of Products by Stage and Top 10 Molecule Types, H1 2015 22

Browse more reports on Infectious Diseases Therapeutics @  http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics .

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.